NCT04681196View on ClinicalTrials.gov

Nasal Versus Oronasal Mask in Continuous Positive Airway Pressure (CPAP) Treatment of Patients Affected by Obstructive Sleep Apnea Syndrome (OSAS).

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

March 1, 2021

Study Completion Date

June 1, 2021

Conditions
Osa Syndrome
Interventions
OTHER

patients shifted to nasal mask after persistent OSA with oronasal mask

In this group were selected OSA patients exhibiting persistent obstructive events and paradoxical obstruction with oronasal masks during CPAP , that were fully recovered (no more OSA detected) with the shift to nasal one

Trial Locations (1)

40138

Azienda Ospedaliero Universitaria Policlinico S. Orsola-Malpighi, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT04681196 - Nasal Versus Oronasal Mask in Continuous Positive Airway Pressure (CPAP) Treatment of Patients Affected by Obstructive Sleep Apnea Syndrome (OSAS). | Biotech Hunter | Biotech Hunter